Question to the Department of Health and Social Care:
To ask Her Majesty's Government what was the cost of treatment with anti-viral drugs for each hepatitis C patient treated by NHS England in 2016–17.
Hepatitis C medicines are subject to commercially confidential pricing agreements so it is not possible to disclose the cost for each patient treated. NHS England spent in excess of £200 million on direct-acting antivirals for hepatitis C in 2016-17.